Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

被引：59
|
作者：
Bornebroek, Marjolijn
de Lau, Lonneke M. L.
Haag, Mendel D. M.
Koudstaal, Peter J.
Hofman, Albert
Stricker, Bruno H. C.
Breteler, Monique M. B.
机构：
[1] Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
来源：
NEUROEPIDEMIOLOGY | 2007年 / 28卷 / 04期
关键词：
nonsteroidal anti-inflammatory drugs; Parkinson disease; inflammation; cohort study;
D O I：
10.1159/000108110
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background: Several lines of evidence suggest a role of inflammatory processes in Parkinson disease, although it is still unclear whether inflammation is a cause or rather a consequence of neurodegeneration. Methods: In a prospective population-based cohort study among 6,512 participants aged 6 55 years, with repeated in-person examination, we evaluated the association between cumulative use of nonsteroidal anti-inflammatory drugs ( NSAIDs) and the risk of Parkinson disease. Complete information on filled prescriptions was available from automated pharmacy records. Data were analyzed by means of Cox proportional hazards regression analysis, adjusted for age, sex, smoking habits and coffee consumption. Results: After an average 9.4 years of follow-up, 88 new cases of Parkinson disease were detected. No association was found between use of NSAIDs and the risk of Parkinson disease ( adjusted hazard ratio for any NSAID use, 1.50; 95% confidence interval, 0.95-2.37). Conclusion: Our findings do not support the hypothesis that NSAIDs might decrease the risk of Parkinson disease. Copyright (c) 2007 S. Karger AG, Basel
引用
收藏
页码：193 / 196
页数：4
相关论文
共 50 条
  • [1] Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
    Chen, HL
    Zhang, SMM
    Hernán, MA
    Schwarzschild, MA
    Willett, WC
    Colditz, GA
    Speizer, FE
    Ascherio, A
    ARCHIVES OF NEUROLOGY, 2003, 60 (08) : 1059 - 1064
  • [2] Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease
    Chen, H
    Zhang, SM
    Hernan, MA
    Schwarzschild, MA
    Willett, WC
    Colditz, GA
    MOVEMENT DISORDERS, 2002, 17 : S143 - S144
  • [3] Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease
    Ton, Thanh G.
    Heckbert, Susan R.
    Longstreth, W. T., Jr.
    Rossing, Mary Anne
    Kukull, Walter A.
    Franklin, Gary M.
    Swanson, Phillip D.
    Smith-Weller, Terri
    Checkoway, Harvey
    MOVEMENT DISORDERS, 2006, 21 (07) : 964 - 969
  • [4] Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease
    Hernán, MA
    Logroscino, G
    Rodríguez, LAG
    NEUROLOGY, 2006, 66 (07) : 1097 - 1099
  • [5] Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
    Wahner, Angelika D.
    Bronstein, Jeff M.
    Bordelon, Yvette M.
    Ritz, Beate
    NEUROLOGY, 2007, 69 (19) : 1836 - 1842
  • [6] Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease
    Hancock, Dana B.
    Martin, Eden R.
    Stajich, Jeffrey M.
    Jewett, Rita
    Stacy, Mark A.
    Scott, Burton L.
    Vance, Jeffery M.
    Scott, William K.
    ARCHIVES OF NEUROLOGY, 2007, 64 (04) : 576 - 580
  • [7] Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease
    Corrada, M
    Stewart, W
    Kawas, C
    NEUROLOGY, 1996, 46 (02) : 6015 - 6015
  • [8] Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
    Jeter, Joanne M.
    Bonner, Joseph D.
    Johnson, Timothy M.
    Gruber, Stephen B.
    JOURNAL OF SKIN CANCER, 2011, 2011
  • [9] Nonsteroidal anti-inflammatory drugs and cardiovascular risk
    Howard, PA
    Delafontaine, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 519 - 525
  • [10] Nonsteroidal anti-inflammatory drug use and the risk of Parkinson's disease
    Etminan, M.
    Carleton, B. C.
    Samii, A.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1553 - 1554
12345